← Eichor
Condition: Cerebral Venous Thrombosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cerebral Venous Thrombosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Heat Shock Protein 47 in Thrombosis
Phase N/A · 2 location(s) · University of Aarhus · NCT06731673Dabigatran Versus Apixaban in Cerebral Venous Thrombosis
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06551415Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06531122Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4 · 1 location(s) · Asian Institute Of Medical Sciences · NCT07521332Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
Phase N/A · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT04660747Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Phase 3 · 34 location(s) · Region Stockholm · NCT05679024Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis
Phase 3 · 1 location(s) · Kafrelsheikh University · NCT06551402The Norwegian Cerebral Venous Thrombosis Study
Phase N/A · 1 location(s) · University Hospital, Akershus · NCT05021198Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis
Phase 4 · 1 location(s) · Xuanwu Hospital, Beijing · NCT07352358VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Phase 4 · 1 location(s) · Science Valley Research Institute · NCT06873321Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)
NA · 1 location(s) · Beijing Tiantan Hospital · NCT06583889PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
Phase 3 · 12 location(s) · Sunnybrook Health Sciences Centre · NCT03559114Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is
Phase 3 · 18 location(s) · Regeneron Pharmaceuticals · NCT07430956DOAC in Chinese Patients With Atrial Fibrillation
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05378035Evaluation of the SCALED (SCaling AcceptabLE cDs)
Phase N/A · 1 location(s) · University of Minnesota · NCT05628207Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage
NA · 1 location(s) · Pirogov Russian National Research Medical University · NCT06753786Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
Phase N/A · 1 location(s) · Xuanwu Hospital, Beijing · NCT06947707Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam
Phase N/A · 1 location(s) · Hieu Trung Dinh · NCT07083609Impact of COVID-19 Vaccines on Cerebrovascular Health
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT04992195GEKO Venous Thromboembolism Prevention Study
NA · 18 location(s) · Firstkind Ltd · NCT05476913Cerebral Venous Thrombosis Cohort Study in China Mainland
Phase N/A · 1 location(s) · Capital Medical University · NCT03919305
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.